CERTARA INC. - COMMON STOCK

Certara to Report First Quarter 2022 Financial Results on May 5th, 2022

20 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

Certara Reports Fourth Quarter and Full Year 2021 Financial Results

01 Mar 2022 15:15:00 By Nasdaq GlobeNewswire

U.S. FDA Licenses Certara’s Immunogenicity Simulator

23 Feb 2022 15:30:00 By Nasdaq GlobeNewswire

Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive Year

15 Feb 2022 15:30:00 By Nasdaq GlobeNewswire

Certara to Report Fourth Quarter and Full Year 2021 Financial Results on March 1st, 2022

08 Feb 2022 15:30:00 By Nasdaq GlobeNewswire

Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions

21 Dec 2021 07:00:01 By Nasdaq GlobeNewswire

Certara Announces Release of Pinnacle 21 Enterprise Software

13 Dec 2021 07:00:01 By Nasdaq GlobeNewswire

Certara to Host Investor Day on December 15, 2021

08 Dec 2021 16:00:00 By Nasdaq GlobeNewswire

Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory Guidances

02 Dec 2021 07:00:01 By Nasdaq GlobeNewswire

Certara Announces Update of D360™ Scientific Informatics Software

29 Nov 2021 15:30:00 By Nasdaq GlobeNewswire

Certara Announces Closing of Public Offering of Common Stock

22 Nov 2021 16:45:00 By Nasdaq GlobeNewswire

Certara Announces Pricing of Public Offering of Common Stock

17 Nov 2021 22:27:02 By Nasdaq GlobeNewswire

Certara Announces Proposed Public Offering of Common Stock

15 Nov 2021 16:30:00 By Nasdaq GlobeNewswire

Certara Reports Third Quarter 2021 Financial Results

09 Nov 2021 15:10:00 By Nasdaq GlobeNewswire

Certara Appoints James E. Cashman III as Chairman of Board of Directors

08 Nov 2021 15:30:00 By Nasdaq GlobeNewswire

Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference

03 Nov 2021 07:00:00 By Nasdaq GlobeNewswire

Pinnacle 21 Awarded FDA Contract for 5 Years for Software and Services

28 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award

25 Oct 2021 15:30:00 By Nasdaq GlobeNewswire

Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021

19 Oct 2021 07:00:02 By Nasdaq GlobeNewswire

Certara Appoints Patrick F. Smith to President of Integrated Drug Development

12 Oct 2021 07:00:02 By Nasdaq GlobeNewswire